DK0659412T3 - Metode til hæmning af symptomerne ved præmenstruelt syndrom/sen lutealfase dysfor lidelse - Google Patents
Metode til hæmning af symptomerne ved præmenstruelt syndrom/sen lutealfase dysfor lidelseInfo
- Publication number
- DK0659412T3 DK0659412T3 DK94309466T DK94309466T DK0659412T3 DK 0659412 T3 DK0659412 T3 DK 0659412T3 DK 94309466 T DK94309466 T DK 94309466T DK 94309466 T DK94309466 T DK 94309466T DK 0659412 T3 DK0659412 T3 DK 0659412T3
- Authority
- DK
- Denmark
- Prior art keywords
- symptoms
- inhibiting
- premenstrual syndrome
- luteal phase
- dysphoric disorder
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/171,148 US5389670A (en) | 1993-12-21 | 1993-12-21 | Methods of inhibiting the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0659412T3 true DK0659412T3 (da) | 2002-06-17 |
Family
ID=22622728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94309466T DK0659412T3 (da) | 1993-12-21 | 1994-12-19 | Metode til hæmning af symptomerne ved præmenstruelt syndrom/sen lutealfase dysfor lidelse |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US5389670A (da) |
| EP (1) | EP0659412B1 (da) |
| JP (1) | JPH07196503A (da) |
| KR (1) | KR950016737A (da) |
| CN (1) | CN1108255A (da) |
| AT (1) | ATE214927T1 (da) |
| AU (1) | AU8155994A (da) |
| CA (1) | CA2138505A1 (da) |
| CZ (1) | CZ321894A3 (da) |
| DE (1) | DE69430232T2 (da) |
| DK (1) | DK0659412T3 (da) |
| ES (1) | ES2170767T3 (da) |
| HU (1) | HUT71338A (da) |
| IL (1) | IL112054A0 (da) |
| NO (1) | NO944921L (da) |
| PT (1) | PT659412E (da) |
| RU (1) | RU94044488A (da) |
| ZA (1) | ZA9410077B (da) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6515009B1 (en) * | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US5811447A (en) * | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US6251920B1 (en) | 1993-05-13 | 2001-06-26 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
| US5770609A (en) | 1993-01-28 | 1998-06-23 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
| US6395494B1 (en) | 1993-05-13 | 2002-05-28 | Neorx Corporation | Method to determine TGF-β |
| US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US5595722A (en) * | 1993-01-28 | 1997-01-21 | Neorx Corporation | Method for identifying an agent which increases TGF-beta levels |
| ATE406909T1 (de) * | 1993-05-13 | 2008-09-15 | Poniard Pharmaceuticals Inc | Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind |
| US6197789B1 (en) | 1995-06-07 | 2001-03-06 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| US6417198B1 (en) | 1993-12-21 | 2002-07-09 | Eli Lilly And Company | Methods of inhibiting CNS problems in post-menopausal women |
| US20030083733A1 (en) * | 1997-10-10 | 2003-05-01 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US5514704A (en) * | 1995-03-13 | 1996-05-07 | Eli Lilly And Company | Benzothiophenes to inhibit leukotrienes |
| US5837313A (en) * | 1995-04-19 | 1998-11-17 | Schneider (Usa) Inc | Drug release stent coating process |
| US6099562A (en) * | 1996-06-13 | 2000-08-08 | Schneider (Usa) Inc. | Drug coating with topcoat |
| US20020091433A1 (en) * | 1995-04-19 | 2002-07-11 | Ni Ding | Drug release coated stent |
| US5985932A (en) * | 1996-02-28 | 1999-11-16 | Pfizer Inc | Inhibition of autoimmune diseases |
| IL120266A (en) | 1996-02-28 | 2005-05-17 | Pfizer | Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions |
| TW442286B (en) * | 1996-02-28 | 2001-06-23 | Pfizer | New therapeutic uses of estrogen agonists |
| IL120262A (en) * | 1996-02-28 | 2001-01-28 | Pfizer | Droloxifene and derivatives thereof for use in increasing serum testosterone levels |
| US5733937A (en) * | 1996-02-28 | 1998-03-31 | Pfizer Inc. | Methods for alleviating symptoms of premenstrual syndrome and late luteal phase dysphoric disorder |
| US6110942A (en) * | 1996-06-17 | 2000-08-29 | Eli Lilly And Company | Method for minimizing the uterotrophic effect of droloxifene |
| ZA982877B (en) * | 1997-04-09 | 1999-10-04 | Lilly Co Eli | Treatment of central nervous system disorders with selective estrogen receptor modulators. |
| US6117911A (en) * | 1997-04-11 | 2000-09-12 | Neorx Corporation | Compounds and therapies for the prevention of vascular and non-vascular pathologies |
| US6008232A (en) * | 1997-08-20 | 1999-12-28 | Eli Lilly And Company | Methods for preventing headaches |
| US6096781A (en) | 1997-11-14 | 2000-08-01 | Eli Lilly And Company | 2-arylbenzo[B]thiophenes useful for the treatment of estrogen deprivation syndrome |
| US6288108B1 (en) | 1998-06-16 | 2001-09-11 | Eli Lilly And Company | Methods for increasing levels of acetylcholine |
| TR200003704T2 (tr) | 1998-06-16 | 2001-06-21 | Eli Lilly And Company | Asetilkolin düzeylerini arttırma |
| US6258826B1 (en) | 1998-10-13 | 2001-07-10 | Eli Lilly And Company | Pharmaceutical formulations and applications thereof for the treatment of estrogen deprivation syndrome |
| US6613083B2 (en) * | 2001-05-02 | 2003-09-02 | Eckhard Alt | Stent device and method |
| CN101128550B (zh) * | 2005-01-10 | 2013-01-02 | 耶路撒冷希伯来大学伊萨姆研发公司 | 金属纳米颗粒的水基分散液 |
| JP2022545960A (ja) * | 2019-08-26 | 2022-11-01 | ピリオド ピル ベーフェー | 月経周期性症状の治療 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4133814A (en) * | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
| US4418068A (en) * | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
| US4380635A (en) * | 1981-04-03 | 1983-04-19 | Eli Lilly And Company | Synthesis of acylated benzothiophenes |
| US5075321A (en) * | 1987-03-24 | 1991-12-24 | University Of Pennsylvania | Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes |
| US5395842A (en) * | 1988-10-31 | 1995-03-07 | Endorecherche Inc. | Anti-estrogenic compounds and compositions |
| JP3157882B2 (ja) * | 1991-11-15 | 2001-04-16 | 帝国臓器製薬株式会社 | 新規なベンゾチオフエン誘導体 |
-
1993
- 1993-12-21 US US08/171,148 patent/US5389670A/en not_active Expired - Fee Related
-
1994
- 1994-08-29 US US08/297,350 patent/US5550150A/en not_active Expired - Fee Related
- 1994-12-19 CA CA002138505A patent/CA2138505A1/en not_active Abandoned
- 1994-12-19 RU RU94044488/14A patent/RU94044488A/ru unknown
- 1994-12-19 JP JP6314600A patent/JPH07196503A/ja active Pending
- 1994-12-19 AT AT94309466T patent/ATE214927T1/de not_active IP Right Cessation
- 1994-12-19 KR KR1019940034928A patent/KR950016737A/ko not_active Application Discontinuation
- 1994-12-19 IL IL11205494A patent/IL112054A0/xx unknown
- 1994-12-19 NO NO944921A patent/NO944921L/no unknown
- 1994-12-19 ES ES94309466T patent/ES2170767T3/es not_active Expired - Lifetime
- 1994-12-19 ZA ZA9410077A patent/ZA9410077B/xx unknown
- 1994-12-19 DK DK94309466T patent/DK0659412T3/da active
- 1994-12-19 AU AU81559/94A patent/AU8155994A/en not_active Abandoned
- 1994-12-19 HU HU9403671A patent/HUT71338A/hu unknown
- 1994-12-19 CN CN94119273A patent/CN1108255A/zh active Pending
- 1994-12-19 DE DE69430232T patent/DE69430232T2/de not_active Expired - Fee Related
- 1994-12-19 PT PT94309466T patent/PT659412E/pt unknown
- 1994-12-19 EP EP94309466A patent/EP0659412B1/en not_active Expired - Lifetime
- 1994-12-19 CZ CZ943218A patent/CZ321894A3/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH07196503A (ja) | 1995-08-01 |
| DE69430232D1 (de) | 2002-05-02 |
| AU8155994A (en) | 1995-06-29 |
| ES2170767T3 (es) | 2002-08-16 |
| ATE214927T1 (de) | 2002-04-15 |
| US5550150A (en) | 1996-08-27 |
| EP0659412A3 (en) | 1995-09-06 |
| DE69430232T2 (de) | 2002-11-14 |
| US5389670A (en) | 1995-02-14 |
| CA2138505A1 (en) | 1995-06-22 |
| HUT71338A (en) | 1995-11-28 |
| RU94044488A (ru) | 1996-10-20 |
| HU9403671D0 (en) | 1995-02-28 |
| NO944921L (no) | 1995-06-22 |
| EP0659412A2 (en) | 1995-06-28 |
| CN1108255A (zh) | 1995-09-13 |
| NO944921D0 (no) | 1994-12-19 |
| PT659412E (pt) | 2002-08-30 |
| EP0659412B1 (en) | 2002-03-27 |
| KR950016737A (ko) | 1995-07-20 |
| ZA9410077B (en) | 1996-06-19 |
| IL112054A0 (en) | 1995-03-15 |
| CZ321894A3 (en) | 1995-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0659412T3 (da) | Metode til hæmning af symptomerne ved præmenstruelt syndrom/sen lutealfase dysfor lidelse | |
| DK0652001T3 (da) | Fremgangsmåder til behandling af det perimenopausale syndrom | |
| ATE296821T1 (de) | Triarylimidazol-derivate als cytokin-inhibitoren | |
| DE69406914D1 (de) | Eine styren-gruppe enthaltende uv-absorbierende benzotriazole | |
| ATE185558T1 (de) | Prostaglandin-synthase hemmer | |
| DK0869946T3 (da) | Phenylimidazolidiner og deres anvendelse som anti-androgent middel | |
| NO20002440D0 (no) | Hydroksam- og karboksylsyrederivater med MMP- og TNF- inhiberende aktivitet | |
| NO944919L (no) | Fremgangsmåte for å inhibere atrofi av huden eller vagina | |
| DK0669936T3 (da) | Mercaptoacetylamidsubstitueret bicyklisk lactam til anvendelse som enkephalinase- og ACE-inhibitorer | |
| DK0651999T3 (da) | Fremgangsmåder til inhibering af livmoderfibrose | |
| DE69412049T2 (de) | Hemmung von dysfunctionalen Uterusblutungen | |
| DE69428877T2 (de) | Hemmung einer Fehlentwicklung der Ovarien, verspüteter Pubertät oder sexuellem Infantilismus | |
| EA199800152A1 (ru) | Лечение синдрома дефицита внимания/гиперактивности | |
| ATE92960T1 (de) | Alpha-1-antitrypsin-varianten, besonders verwendbar als kallikrein-inhibitoren. | |
| EA199800015A1 (ru) | Способ ингибирования меланомы | |
| UA26459C2 (uk) | Іhгібітор впливу амілоїдhих білків | |
| NO924806L (no) | Etanoladdukter av 6-sulfonylsubstituerte 3-hydroksykromaner og deres anvendelse som inhalasjonsmiddel ved sykdommer | |
| EA200000243A1 (ru) | Способы снижения количества тромбоцитов | |
| EA199700200A1 (ru) | Способы ингибирования рака яичника | |
| ATE384149T1 (de) | Hydrophilieadditive | |
| TH23898B (th) | วิธีการหยุดยั้งการออกฤทธิ์ของ il-6 | |
| TH27901B (th) | "1h-อิมิดาโซลที่ถูกเข้าแทนที่" | |
| TH23898A (th) | วิธีการหยุดยั้งการออกฤทธิ์ของ il-6 |